|06/29/16 06:29 PM||Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Earnings Review and Target Focus - Telanagana Press|
|06/28/16 06:26 PM||Covering the Bases on Sarepta Therapeutics, Inc. (NASDAQ:SRPT): Where is the Stock Going? - Press Telegraph|
|06/28/16 06:26 PM||Sarepta Therapeutics, Inc. (NASDAQ:SRPT): Reviewing Stock Performance - Press Telegraph|
|06/28/16 03:32 PM||SAREPTA THERAPEUTICS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders - |
|06/28/16 08:39 AM||Sarepta Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : SRPT-US : June 28, 2016 - |
|06/27/16 06:26 PM||Drug Trial Extension By FDA Doesn't Change Baird's Outlook On Sarepta|
|06/27/16 03:35 PM||Why Sarepta just made its soon-to-begin drug trial even longer - |
|06/27/16 01:35 PM||Still Little Hope Of FDA Approval For Sarepta, SunTrust Says Sell - |
|06/26/16 10:39 AM||William Blair Weighs In on Sarepta Therapeutics Inc (SRPT) Following Changes In ESSENCE Trial - Smarter Analyst|
|06/26/16 09:12 AM||3 Tempting Stocks to Avoid - |
|06/23/16 02:50 PM||Sarepta Therapeutics: Radio Silence - |
|06/23/16 02:07 PM||Sarepta Push for Duchenne Drug Approval Helped by Clinical Trial Changes - |
|06/22/16 10:34 AM||Sarepta Therapeutics (NASDAQ:SRPT) Analyst Rating Consensus - Trade Calls|
|06/21/16 10:31 AM||Oppenheimer Pounds the Table on Sarepta Therapeutics Inc (SRPT) - Smarter Analyst|
|06/20/16 08:02 AM||Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Analyst Price Targets For The Coming Week - Fiscal Standard|
|06/18/16 10:36 AM||Sarepta Therapeutics Inc. (SRPT) Drops 7.9% on June 16 - Equities.com|
|06/17/16 07:15 AM||Sarepta Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : SRPT-US : June 17, 2016 - |
|06/16/16 06:46 PM||Ratings Analysis of: Sarepta Therapeutics, Inc. (NASDAQ:SRPT) - News Oracle|
|06/16/16 06:46 PM||This Hot Stock is Trending: Sarepta Therapeutics, Inc. (NASDAQ:SRPT) - News Oracle|
|06/15/16 06:27 PM||Analyst Earnings Report: UBS Group AG (NYSE:UBS), Sarepta Therapeutics, Inc. (NASDAQ:SRPT) - Beacon Chronicle|
|06/14/16 06:13 PM||Analyst's Valuable Buzzers: Valeant Pharmaceuticals (NYSE:VRX) , Sarepta Therapeutics, (NASDAQ:SRPT) - Street Updates|
|06/14/16 06:13 PM||Analyst Overview: Huntsman Corporation (NYSE:HUN), Sarepta Therapeutics, Inc. (NASDAQ:SRPT) - Beacon Chronicle|
|06/14/16 08:47 AM||Sarepta seen holding onto recent gains - |
|06/13/16 06:06 PM||Analyst Recommendations on These Hot Stocks: Canadian Solar Inc. (NASDAQ:CSIQ), Sarepta Therapeutics, Inc ... - Beacon Chronicle|
|06/13/16 09:33 AM||HC Stocks Movements: Brookdale Senior Living, Inc. (NYSE:BKD), Sarepta Therapeutics Inc (NASDAQ:SRPT) - share market updates (press release)|
|06/11/16 09:31 AM||Price Target Highlight: Sarepta Therapeutics, Inc. (NASDAQ:SRPT) - News Oracle|
|06/10/16 06:55 PM||Biotech Updates: Analysts Offer Commentary on Gilead Sciences, Inc. (GILD) and Sarepta Therapeutics Inc (SRPT) - Smarter Analyst|
|06/10/16 03:34 PM||SAREPTA THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial St - |
|06/10/16 12:26 PM||Sarepta Therapeutics: And Now We Wait - |
|06/10/16 09:36 AM||Biogen Inc (NASDAQ:BIIB) & Sarepta Therapeutics (NASDAQ:SRPT) are Hot Stocks - Wall Street 24|
|06/10/16 09:36 AM||Earnings Expectations of the Stocks: Sarepta Therapeutics, Inc. (NASDAQ:SRPT), Regions Financial Corporation ... - Beacon Chronicle|
|06/09/16 07:04 PM||Analyst Earnings Report: Sarepta Therapeutics, Inc. (NASDAQ:SRPT), Seagate Technology plc (NASDAQ:STX) - Beacon Chronicle|
|06/09/16 07:04 PM||Sarepta Therapeutics Inc: Piper Jaffray Upgrades Stock to Neutral - Bidness ETC|
|06/09/16 07:04 PM||Sarepta Therapeutics Inc. (SRPT) Jumps 7.97% on June 09 - Equities.com|
|06/09/16 05:27 PM||Why Envision Healthcare Holdings, Sarepta Therapeutics, and ABM Industries Jumped Today - Despite a slight market drop, these stocks gained ground. Find out why.|
|06/09/16 02:37 PM||Mid-Afternoon Market Update: Tailored Brands Tumbles On Downbeat Results; Sarepta Therapeutics Shares Spike Higher -
Toward the end of trading Thursday, the Dow traded down 0.27 percent to 17,956.77 while the NASDAQ declined 0.47 percent to 4,951.13. The S&P also fell, dropping 0.34 percent to 2,112.01.
Leading and Lagging Sectors
Thursday afternoon, the utilities sector proved to be a source of strength for the market. Leading the sector was strength from Ameren Corp (NYSE: AEE) and Great Plains Energy Incorporated (NYSE: GXP).
In trading on Thursday, basic materials shares fell by 1.9 percent. Meanwhile, top losers in the sector included Companhia Siderurgica Nacional (ADR) (NYSE: SID), down 9 percent, and Vale SA (ADR) (NYSE: VALE), down 9 percent.
J M Smucker Co (NYSE: SJM) reported stronger-than-expected earnings for its fourth quarter and offered upbeat forecast for the fiscal year 2017.
J.M. Smucker Company reported net income of $191 million or $1.61 a share compared to a net loss of $90.3 million or a loss of $0.82 a share in the year-ago quarter. On an adjusted basis, it would have earned $1.86 a share, sharply up ...Full story available on Benzinga.com|
|06/09/16 11:54 AM||9 Biggest Mid-Day Gainers For Thursday - Jaguar Animal Health Inc (NASDAQ: JAGX) shares jumped 95.45 percent to $2.58 as the company reported $15 million stock purchase agreement with Aspire Capital Fund, LLC.
Staffing 360 Solutions Inc (NASDAQ: STAF) shares surged 32.82 percent to $2.59. Staffing 360 expects Q4 sales of $44 million and FY16 revenue of $165 million.
Christopher & Banks Corporation (NYSE: CBK) shares climbed 14.36 percent to $2.31 as the company reported better-than-expected Q1 results.
Sarepta Therapeutics Inc (NASDAQ: Full story available on Benzinga.com|
|06/09/16 09:39 AM||Analyst Review: Sarepta Therapeutics, Inc. (NASDAQ:SRPT) - News Oracle|
|06/09/16 09:39 AM||Sarepta Therapeutics Inc Headed Towards Accelerated Approval for Eteplirsen: Wedbush - Bidness ETC|
|06/09/16 09:39 AM||HC Stocks To Observe: Sarepta Therapeutics Inc (NASDAQ:SRPT), Gilead Sciences, Inc. (NASDAQ:GILD) - share market updates (press release)|
|06/09/16 09:39 AM||Sarepta Therapeutics Inc. (SRPT) Jumps 22.55% on June 07 - Equities.com|
|06/09/16 08:57 AM||Sarepta Therapeutics: $5 Here We Come? - |
|06/08/16 07:05 PM||Company Update (NASDAQ:SRPT): Sarepta Therapeutics Inc Announces Proposed Offering - Smarter Analyst|
|06/08/16 04:51 PM||After-Hours Social Sentiment In Sarepta Suggests Traders May Be Viewing Offering News As A Positive Indication -
Sarepta Therapeutics Inc (NASDAQ: SRPT) shares have had an extremely volatile after-hours session following news of a $37.5 million offering.
Immediately following the company press release, shares plunged to an after-hours low at $15.50. Shortly after, the stock had trimmed those losses and turned positive from the close, touching an extended-hour high around $20.47.
About 50 minutes after the press release, Sarepta shares last traded at $19.25, down nearly a percent from Wednesday's close.
The offering has caused confusion among investors and traders frequenting social networks like Twitter and StockTwits.
Below are a ...Full story available on Benzinga.com|
|06/08/16 09:40 AM||Performance to see: Sarepta Therapeutics, Inc. (NASDAQ:SRPT) - News Oracle|
|06/08/16 09:40 AM||Analyst's Valuable Buzzers: Sarepta Therapeutics, Inc. (NASDAQ:SRPT) , Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - Street Updates|
|06/08/16 09:40 AM||SAREPTA THERAPEUTICS INC. (NASDAQ:SRPT) Financial Condition Compared to S&P 500 - CML News|
|06/08/16 09:37 AM||Mid-Morning Market Update: Markets Open Higher; Lululemon Reports Mixed Q1 Results -
Following the market opening Wednesday, the Dow traded up 0.41 percent to 18,011.24 while the NASDAQ climbed 0.28 percent to 4,975.64. The S&P also rose, gaining 0.33 percent to 2,119.07.
Leading and Lagging Sectors
Wednesday morning, the basic materials sector proved to be a source of strength for the market. Leading the sector was strength from AK Steel Holding Corporation (NYSE: AKS) and IAMGOLD Corp (USA) (NYSE: IAG).
In trading on Wednesday, healthcare shares fell by 0.05 percent. Meanwhile, top losers in the sector included Enzo Biochem, Inc. (NYSE: ENZ), down 5 percent, and Sarepta Therapeutics Inc (NASDAQ: SRPT), down 5 percent.
Lululemon Athletica inc. (NASDAQ: LULU) reported weaker-than-expected adjusted earnings for the first quarter. However, revenue came in above the expected level. The company's earnings forecast for the second quarter also fell short of the expectations.
Lululemon reported net income of $45.34 million in the first quarter, down from $47.81 million while earnings slipped to $0.33 a share from $0.34 a share in the year-ago quarter. Excluding adjustments, it would have earned only $0.31 a share thus missing the Street analysts' expectations by ...Full story available on Benzinga.com|
|06/08/16 01:04 AM||Sarepta Therapeutics (SRPT): Wedbush Upgrades Stock to Outperform - The firm presently has a $36.00 price target on the stock. They now have a Dollars 5 price target on the stock. It means it could lead to an approval, and shares In Sarepta rose over 40%. Shares of the company rose 24 percent to US$19.90 in extended ...|
|06/07/16 06:50 PM||Sarepta Therapeutics Inc (SRPT) Stock Skyrockets After FDA News - ValueWalk|